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ABSTRACT
Use of high-resolution metabolomics to assess changes in metabolic pathways
associated with acute exposure to air pollutants.
By
ELIZABETH A. FINLON
April 20, 2018
INTRODUCTION: Many studies have examined the positive effects of physical activity on
mortality and morbidity, as well as the negative impact of exposure to air pollutants. Few,
however, have investigated the complex interaction between physical activity and air
pollution exposure. One promising method for analyzing this interaction is using
metabolomics to identify the resulting metabolites produced from each exposure. This
study will provide insight into the modification by physical activity of health biomarkers
associated with acute exposure to air pollutants.
AIM: The aim of this study is to identify novel biomarkers of pollutant exposures using
metabolomics analyses. Specifically, this study will examine differences in exposures to air
pollutants (black carbon, ozone, particulate matter, particle number concentration) and
corresponding metabolic changes in subjects before and after outdoor physical activity.
METHODS: Sixty-five saliva samples for metabolomics analysis were collected from a
sample of 57 individuals in Atlanta, GA from June through July 2016. The ambient outdoor
concentrations of PM2.5 (PM), ozone (O3), black carbon (BC), and particle number
concentration (PNC) were measured throughout each 2-hr sampling event. Each
participant’s physical activity levels were monitored as well. Each pollutant (above) was
analyzed per individual via four separate metrics: ambient outdoor concentration,
exposure, cumulative inhaled dose, and maximum one-minute dose. Samples were
processed via ultra-high resolution liquid chromatography-mass spectrometry. Various
mixed regression models used pollutant metrics to predict changes in metabolic feature
intensity from pre- to post-exposure. Metabolite identification and pathway analysis for
each significant feature was calculated using Mummichog version 1.0.3 with a level of
significance of .05.
RESULTS: All pollutant metrics were significantly associated with changes in metabolic
features. PNC max showed the highest number of significant associations with 172
significantly associated metabolic features. Additionally, Mummichog analysis yielded
significant pathway predictions for all feature metrics, with a total of 48 significant
metabolic pathway predictions
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DISCUSSION: We identified 48 metabolic pathways that showed significant correlation
with air pollution exposure. However, the lack of consistency in pathway predictions
suggests that acute pollution exposure may take more than 2 hours to have a measurable
effect on the salivary metabolome. Our research suggests that while high-resolution
metabolomics shows potential for reliably identifying biomarkers of pollutant-related
stress, there is still much room for further development in this field.
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I. INTRODUCTION
1.1 Background:
Environmental exposures, including pollutants, pharmaceuticals, and pesticides, can have
a significant impact on the development of disease in humans. Environmental components are
understood to play an important role in the development of many chronic diseases such as
“cancer, cardiovascular diseases, respiratory diseases, and type 2 diabetes, which are among the
leading causes of morbidity and mortality in human populations” (Cui et al. 2016). However,
less emphasis has been placed on accurately measuring the environmental component of human
health than has been placed on measuring the impact of one’s genetic makeup. To correct this,
researchers have begun to study the human exposome in order to account for the totality of
human non-genetic exposures throughout a lifetime. The exposome is considered the
environmental compliment to the human genome; understanding the exposome allows for a more
in-depth evaluation of the association between environmental exposures and resulting biological
effects than would examining the genome alone (Louis et al. 2017). Furthermore, recognizing the
role of the complex interaction between one’s genes and specific environmental exposures
allows for a deeper understanding of the impacts of environment on human health.
While physical activity and exposure to air pollutants each have independent (usually
opposing) effects on human health (Fisher et al. 2016), it is important to understand the complex
interplay between these two factors when one is exposed to both simultaneously (Greenwald et
al. 2016). To fully comprehend this interaction, we must recognize which metabolic interactions
occur due to physical activity, which result from exposure to air pollution, and how these
metabolites interact with each other.
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Many studies have examined the positive effects of physical activity on mortality and
morbidity, as well as the negative impact of exposure to air pollutants (Brook et al. 2010,
Fogelholme 2010). Few, however, have investigated the complex interaction between physical
activity and air pollution exposure. One promising method for analyzing this interaction is using
metabolomics to identify the resulting metabolites produced from each exposure.
1.2 Study Objectives:
It is well documented that exposure to air pollution is related to an increase in mortality
and morbidity, particularly cardiovascular and respiratory diseases (Brook et al. 2010, Dominici
et al. 2006, Kataonda et al. 2011). While exposure to air pollutants is known to increase the risk
of premature mortality, the impact of such exposure on metabolite production is not well
documented. Metabolites act as valuable biomarkers of disease development and can provide the
ability to detect diseases at an early stage (Cox et al. 2014). The exact biochemical mechanisms
linking exposure to symptomatic health outcomes are not precisely known, which is why
exploring changes to intermediate metabolites is an important scientific endeavor.
Metabolomics is quickly becoming an effective tool for monitoring disease occurrence in human
populations.
The aim of this study is to identify novel biomarkers of pollutant exposures using
metabolomics analyses. Specifically, this study will examine differences in exposures to air
pollutants (black carbon, ozone, particulate matter, particle number concentration) and
corresponding metabolic changes in subjects before and after outdoor physical activity. This
study will provide insight into the modification by physical activity of health biomarkers
associated with acute exposure to air pollutants.
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II. REVIEW OF THE LITERATURE
2.1 Air pollution and Physical Activity
Both short- and long-term exposure to air pollution are known to negatively impact
mortality and morbidity, particularly through cardiovascular disease, respiratory disease, and
neurological and reproductive disorders (Curtis et al. 2006). The effects of physical inactivity
include obesity and type II diabetes and are consistently associated with increased morbidity and
mortality (Fogelholm 2010, Flegal et al. 2013). Physical activity, which generally has a positive
impact on health, increases one’s ventilation rate and, therefore, in the presence of pollution,
increases the inhaled dose of air pollutants (de Hartog et al. 2010). Additionally, during exercise
1) most air is inhaled through the mouth rather than the nose, thereby bypassing the nasal
mechanisms of large particle filtration and 2) the increase in airflow velocity causes gaseous
pollutants to pass deeper into the respiratory tract than they would if one were not breathing
heavily (Ramos et al. 2015). More research is needed to determine whether the increase in
minute ventilation during physical activity heightens the detrimental effects of short-term air
pollution exposure to the point of outweighing the long-term benefits of physical activity on lung
function (Fisher et al. 2016).
In this study, we focus on four pollutants: particulate matter (PM2.5), ozone (O3), black
carbon (BC), and particle number concentration (PNC). PM2.5 results primarily from vehicle
emissions, diesel, coal combustion, and biomass burning (Pui et al. 2014). Because of its small
size, PM2.5 deposits throughout the respiratory tract, leading to pulmonary and circulatory
diseases (Pui et al. 2014). O3 is a secondary photochemical pollutant that is known to have
adverse human health effects (Jenkin & Clemitshaw 2000). Exposure to elevated concentrations
of O3 has been shown to result in inflammatory response as well as lung epithelial damage
3

(Gryparis et al. 2004). Traffic emissions are the primary source of BC pollution, which is
produced by the incomplete combustion of carbonaceous fuel (Invernizzi et al. 2011). When
inhaled, BC deposits deep into the respiratory tract where it has been shown to cause decreased
lung function (Invernizzi et al. 2011). In urban settings, motor vehicle emissions represent the
primary source of ultrafine particles, exposure to high concentrations of which has been
associated with “elevated total, cardiovascular, and infant mortality” (Zhu et al. 2002, Kappos et
al. 2004).
2.2 Exposome:
The term “exposome,” coined by Christopher P. Wild in 2005, refers to the sum of all
exposures of an individual throughout a lifetime (Vrijheid 2014). The term gives emphasis to the
importance of the environment on human health outcomes and was originally created to align
exposure research efforts with those of the human genome. The exposome functions as the
environmental compliment to the human genome. While “genome” refers to the entirety of an
individual’s internal DNA structure, “exposome” refers to one’s external exposures and the
impact of those exposures on internal processes. Exposome research, therefore, focuses on an
individual’s non-genetic exposures throughout the lifetime. Understanding the impact of human
environmental exposures and behaviors allows for a more complete insight into one’s risk of
disease. Since 2005, when research of the exposome began, the term has come to include
exposure to both chemical components (pollutants, pharmaceuticals, radiation, etc.) as well as
behavioral factors (stress, diet, physical activity, etc.) (Dennis et al. 2017).
Prior to studying the human exposome, “exposures” were viewed as arising strictly
outside of the body. We now understand that bio-chemicals created endogenously such as
metabolites and hormones can alter how our bodies interact with our specific environment,
4

causing a unique biological response (Cui et al. 2016). One important aspect of studying the
human exposome is understanding the importance of each individual’s unique molecular disease
process as a result of one’s specific internal and external exposures.
Studying the human exposome poses a distinct set of challenges. While the human
genome is relatively stable over a lifetime, the human exposome “is a highly variable and
dynamic entity that evolves throughout the lifetime of the individual” (Wild 2005). Additionally,
studying the human exposome requires the ability to differentiate between the effects of many
exposures over a lifetime. This complexity often requires exposome research to be divided into
“focal areas” such as exposures during specific life stages (e.g. prenatal vs. early childhood) (Cui
2016).
Despite the challenges, understanding the effect of one’s environment on gene expression
and disease formation offers the opportunity to provide more effective risk assessment as well as
disease prevention and treatment. Christopher P. Wild anticipates that gaining fundamental
knowledge of “exposure-disease associations” at the human exposome level will serve to
improve our comprehension of “disease etiology at the population level” (Wild 2005).
2.3 Metabolomics:
Metabolites are byproducts of the series of reactions within cells that occur due to any
chemical or non-chemical exposure. This series of individual chemical reactions is referred to as
a “pathway.” Each pathway is comprised of a sequence of intermediate metabolites that, when
grouped together, are unique to the specific pathway. Examples of metabolites include amino
acids, fatty acids, and glucose molecules. (Harris n.d.)
Metabolomics analysis, a method of metabolic profiling, is the study of low molecular
weight (approx. 50-1,500 daltons) metabolites that act as biomarkers for environmental
5

exposures (Cox et al. 2014.) Metabolites are essentially the byproducts of cellular-level
processes, and understanding them reveals the impact of both endogenous and exogenous
exposures on human health. Identifying and tracking alterations in metabolite levels is an integral
step to improving our knowledge of the influence of environmental exposures on human health.
Metabolome analysis can be incorporated into the study of public health via increasing our
understanding of exposure (both chemical and non-chemical), gene-environment interactions,
and disease risk factors (Athersuch 2016).
The study of metabolite biomarkers plays a particularly important role in determining the
effects of environmental exposures. Understanding biomarkers of environmental exposures has
the potential to alleviate some of the issues of misclassification in epidemiologic research,
including inaccurate recall of exposure and inaccurate behavior modeling. In his analysis of
current metabolomics research, Athersuch states that “the human metabolome has the potential
to report directly on a very large number of environmental exposures” and that these metabolites
are detectable using common metabolic profiling methods. (Athersuch 2016)
Saliva is a quick and easy-to-collect medium for the identification of metabolites and
metabolic pathways. It offers a non-invasive, inexpensive approach to metabolite analysis.
Further development of the salivary metabolome will provide a basis for identifying diseaserelated salivary biomarkers. Saliva is made of up approximately 99% water. The remaining 1%
consists of “electrolytes, mucus, cellular debris, proteins, and small molecules” that are
transferred from the blood via passive diffusion (Bessonneau et al. 2017). Thus, saliva displays
various physiological conditions of the body on a molecular scale.
A common method of analyzing salivary metabolites is through liquid chromatographymass spectrometry (LC-MS). Liquid chromatography is used to separate and quantify ions or
6

small molecules in a solvent. Two commonly used chromatography approaches are
hydrophilic-interaction liquid chromatography (HILIC) and reversed-phase liquid C18
chromatography (C18). Each technique utilizes a specific column (either the HILIC or C18
column) to separate chemicals in different ways. When using a HILIC column, hydrophilic
compounds are preferentially retained by the stationary phase and consequently have
longer retention times, whereas when using a C18 column, hydrophilic compounds are
preferentially in the mobile phase with correspondingly short retention times.
Hydrophobic compounds display the corresponding inverse relationship. (Simon et al.
2012)
In this study, the term “feature” is used to describe an unknown metabolite. A feature
may be found in both C18 and HILIC datasets, but it will have different retention times on each
column. Following liquid chromatography, mass spectrometry is used to ionize molecules in a
sample and then sort the ions based on their mass-to-charge (m/z) ratio. Combining liquid
chromatography’s ability to separate molecules with mass spectrometry’s capability to identify
individual molecules based on mass allows for an in-depth analysis of various chemical
compounds in any given saliva sample (Sugimoto et al. 2010).
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III. METHODS
3.1 Data Collection:
Data for this study was provided by the Study of Air Pollution and Physical Activity
(SAPPA). The data was collected in Atlanta, GA from June through July 2016. The Georgia
State University Institutional Review Board and the Emory University Institutional Review
Board provided approval for this study. Adults provided written consent while individuals under
the age of 18 provided both written and parental consent.
Samples for metabolomics analysis were collected from a sample of 57 individuals on an
ultimate Frisbee team at Walker Park, on a soccer team at Piedmont Park, and at a football
practice at Carver High School. The samples were collected over 9 sampling days. Repeated
measures were performed on some of the participants on multiple days, resulting in 65 total
samples from the 57 participants. The exposure period was an interval of approximately 2 hours,
during which participants engaged in either athletic practice or competition. Prior to the
beginning of physical activity, we recorded each participant’s self-reported date of birth, sex, and
race and measured their height and weight. At the beginning and end of each day of
participation, we collected a 1 mL saliva sample from study subjects and directed them in the
performance of a pulmonary function test using a handheld spirometer (EasyOne Plus, ndd
Medical Technologies Inc.). These tests included forced vital capacity (FVC), which is the
volume of air that a person can forcibly exhale from their lungs with ordinary effort. In addition,
participants were fitted with an electronic biomonitoring device (BioHarness 3, Zephyr
Technology Corp.) worn as a strap around the torso. This device measures motion using
accelerometry as well as heart and breathing rates. Accelerometry data is reported as an activity
parameter (ACT), which is the magnitude of the vector sum of 3-dimensional acceleration,
8

expressed as a fraction of standard gravity (G-force). All BioHarness data is aggregated to oneminute time resolution. Minute ventilation, or the volume of air a person inhales in one minute,
is calculated according to an extensively-validated model developed by Greenwald and Hayat
(personal communication) as a function of heart rate, breathing rate, age, height, sex, and FVC.
The inhaled dose of an air pollutant is calculated as the product of minute ventilation and
ambient concentration (described below).
We continuously measured the ambient concentration of several important gas- and
particle-phase air pollutants. We measured PM2.5 (PM) using an Optical Particle Sizer (Model
3330, TSI Inc.), ozone (O3) using a Model 202 Ozone Monitor (2B Tech), black carbon (BC)
using a microaethalometer (Model AE51, Aethlabs Inc.), and particle number concentration
(PNC) using a NanoScan particle sizer (Model 3306, TSI Inc.). Previous studies have shown that
the majority of PM2.5 mass in the Atlanta area is secondary in nature and thus somewhat spatially
homogenous (Bates et al. 2015). O3 is an entirely secondary pollutant and is spatially
homogenous as well (Wade et al. 2006); however, BC and PNC are closely associated in the
near-road environment with fresh emissions from diesel and gasoline sources, respectively (Zhu
et al. 2002).
This study analyzed each pollutant (above) using four separate metrics: ambient
concentration, exposure, cumulative inhaled dose, and maximum one-minute dose. The ambient
concentration exposure metric is defined as the average concentration of each pollutant during
the exposure period as described above. The metric termed “exposure” is the average
concentration of each pollutant multiplied by the length of the exposure period. Cumulative
inhaled dose is the sum of all one-minute doses in an exposure period, and the maximum oneminute dose metric is included in order to determine whether short-term (one-minute) exposures
9

have a significant impact on changes in metabolic profiles. The a priori expected order of
biological relevance of these pollutant metrics was concentration, exposure, dose, with dose
being the most relevant.
3.2 Analysis:
Sixty-five sets of saliva samples were collected and processed via ultra-high resolution
LC-MS, resulting in a dataset of individual metabolic “features” identified by their mass-tocharge (m/z) ratios as well as retention times (rTime). These features indicate the change in an
individual’s metabolic profile from pre- to post-exposure. These results were divided into two
datasets based on the column utilized during liquid chromatography, C18 and HILIC. The C18
dataset consisted of 7,608 features, and the HILIC dataset consisted of 8,293 features. It is
important to note that the same feature may appear in both datasets.
Each of the 65 samples was run through LC-MS three times. The chromatographic
intensity values of the triplicate results were averaged to yield a single set of values per each m/z
ratio. Next, we calculated the change in feature abundance as the post-exposure intensity minus
the pre-exposure intensity. The resulting averages were then log-transformed in order to interpret
the patterns in the data. Data was analyzed using RStudio version 3.3.3 packages lme4 and
lmerTest to run various mixed regression models that used pollutant metrics to predict changes in
feature intensity. Linear mixed models used each pollutant metric (exposure, dose, concentration,
and maximum dose of BC, PNC, O3, and PM) as the predictor while controlling for the
following covariates: age, race, BMI, sex, and activity level during practice, allowing us to
identify associations between changes in pollution metrics and changes in the presence of
metabolic features from pre- to post-exposure. Because our dataset contained repeated measures

10

for some subjects, we included a random effect for subject in our models. The general linear
mixed model was formulated as follows:
∆𝐹𝑒𝑎𝑡𝑢𝑟𝑒!" = 𝜇 + 𝜃! + 𝛽! ∆𝑃𝑜𝑙𝑙𝑢𝑡𝑎𝑛𝑡 𝑀𝑒𝑡𝑟𝑖𝑐!" + 𝛽! 𝐴𝑔𝑒! + 𝛽! 𝑆𝑒𝑥! + 𝛽! 𝐵𝑀𝐼! + 𝛽! 𝑅𝑎𝑐𝑒!
+ 𝛽! 𝐴𝑐𝑡!" + 𝜀!" ,
where i indexes subject and j indexes sampling day.
Models with pollutant metrics as the predictor were also run without controlling for activity in
order to determine the features likely related to activity (metabolites produced by biochemical
processes related to physical activity) rather than pollutant exposure. Additionally, we ran a
variation of the above model in order to assess the association between activity and metabolite
production, without controlling for any pollution metrics:
∆𝐹𝑒𝑎𝑡𝑢𝑟𝑒!" = 𝜇 + 𝜃! + 𝛽! 𝐴𝐶𝑇!" + 𝛽! 𝐴𝑔𝑒! + 𝛽! 𝑆𝑒𝑥! + 𝛽! 𝐵𝑀𝐼! + 𝛽! 𝑅𝑎𝑐𝑒! + 𝜀!" ,
where indexing of variables and errors are as described for model 1.
We ran these additional models because of the high correlation between the activity variable and
factors used to measure ventilation rate, and by extension, dose.
The models were run through a metabolome-wide association framework, and p-values
for the strength of association between each pollution metric and feature intensity were created.
The p-values for each pollutant metric were adjusted for type I statistical errors using the
Benjamini-Hotchberg false discovery rate (FDR) at FDR <0.05. The FDR is used to control for
the expected proportion of false discoveries in any statistical analysis. At the <0.05 adjustment
level, 5% of significant tests will result in false positives, rather than 5% of all tests resulting in
false positives. This step is required because each model is repeated for every feature, resulting
in thousands of p-values associated with each pollutant metric. The results of the FDR adjusted
p-values were displayed via Manhattan plots of the –log10(p) over the feature retention time.
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Metabolite identification and pathway analysis for each significant feature was calculated
using Mummichog version 1.0.3 with a cutoff significance value of <0.05. Mummichog is a
pathway analysis tool utilizing several libraries containing thousands of positively-identified
metabolites with known m/z ratios. Mummichog predicts functional activity of metabolic
features by computing “all possibly matched metabolites, and [it] searches the reference
metabolic network for all the modules that can be formed by these tentative metabolites” (Li et
al. 2013). The reference metabolic network used in Mummichog analysis is based on KEGG,
UCSD Recon1 and Edinburgh human metabolic network (Li et al. 2013). The results we
gathered from Mummichog convey the probability of the contribution of individual metabolic
pathways to the response to acute air pollution exposure. Pathways from the experimental dataset
were considered significant if they displayed at least 2 overlapping nodes with a given pathway
and had a Mummichog calculated p-value of <0.05.
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IV. RESULTS
Sixty-five saliva samples were collected from 57 participants over 9 separate sampling
events. Characteristics of the sample population are described in Table 1. Pollutant metric values
are indicated in Table 2.
After the FDR adjustment, all pollutant metrics for both C18 and HILIC datasets were
significantly associated with changes in metabolic features. This is displayed in Table 3. PNC
max showed the highest number of significant associations with 172 (73 from C18 and 99 from
HILIC) significantly associated metabolic features. The Manhattan plots for PNC max are
provided in Figure 1. In the plots, the direction of change from pre- to post-exposure for each
feature is indicated by color; the effect size for each feature is indicated by color intensity. Each
plot features 3 FDR-corrected significance levels: 0.05, 0.10, and 0.20 represented by the red,
blue, and black lines, respectively. Figure 2 includes the Manhattan plots for BC dose. BC dose
provides an example of a more representative sample of the data collected in this study. Black
carbon is a pollutant known to cause adverse health effects post-exposure. Additionally, dose is
dependent upon both exposure and activity level, making it potentially the most biologically
relevant exposure metric included in the study.
The Mummichog analysis yielded significant pathway predictions for all feature metrics.
The results of this analysis are displayed in Table 4.

13

V. DISCUSSION
5.1 Discussion of Results:
Of the 48 significant metabolic pathways via the Mummichog analysis, 20 are known to
be associated with deleterious effects of air pollution exposure. Glutathione, for instance, was
found to be significantly associated with PNC concentration and exposure as well as BC
concentration. Glutathione is an antioxidant that responds to airway inflammation. Increases in
glutathione-related oxidative stress have been associated with cause-specific mortality (Breton
2010 & Weichenthal 2015). Leukotrienes are known bronchoconstrictors that play an important
role in both “triggering acute asthma attacks and in causing longer term hypersensitivity of the
airways in chronic asthma” cases (Berger 1999). Leukotrienes also play an important role in
airway inflammation processes in people without asthma. Seeing an upregulation of these
metabolites in healthy individuals could provide insight into the effects of pollutant exposure on
lung health in non-asthmatics. In this analysis, leukotriene metabolism was found to be
significantly associated with PNC max, concentration, and exposure; BC dose; and PM max. In
their 2008 study, Park et al. demonstrate that exposure to traffic-related ambient particles is
associated with elevated plasma concentrations of homocysteine, an acid produced during
methionine metabolism that “is a risk factor for atherosclerosis, myocardial infarction, stroke,
and thrombosis” (Park et al. 2008). Additionally, aspartate, asparagine, tryptophan, and tyrosine
are amino acids that have been linked to air pollution exposure in vivo and in vitro studies
(Vlaanderen et al. 2017). The upregulation of glycerophospholipid metabolism, which we found
to be highly correlated with PNC concentration, exposure, dose; Ozone exposure; and BC
exposure, has previously been found to be associated with PM exposure from cigarette smoke in
mice (Titz et al. 2016).
14

Based on earlier research, 5 of the 48 significant metabolic pathways can be attributed to
the participants’ physical activity levels rather than their exposure to air pollution. These
pathways include purine metabolism, hexose phosphorylation, glycolysis and gluconeogenesis,
and beta-alanine metabolism. (Zielinski & Kusy 2015, Bruunsgaard 2005, Hobson et al. 2012)
One of the expected results in this analysis was a consistent pattern of significant effects
across the exposure metrics for a given pollutant. This is because exposure misclassification is
reduced for more biologically relevant exposure metrics. For example, if two hypothetical
subjects (A and B) experienced the same mean concentration of pollutants, but subject A was
present for 90 minutes while subject B was present for 120 minutes, the time-corrected exposure
metric would reflect this difference whereas the “concentration” exposure metric would not.
Likewise, if subject A was relatively sedentary while subject B was very active with a higher
ventilation rate, then the “dose” exposure metric would reflect this difference while the timecorrected exposure would not. We hypothesized that as the biological relevance of a pollutant
metric increases (e.g. from concentration to exposure to dose), the list of significantly associated
metabolites would decrease (by eliminating spurious associations resulting from exposure
misclassification) but not change entirely. In reality, the lists of associated metabolites had little
to no overlap among metrics. This surprising finding could potentially be explained in a few
non-mutually-exclusive ways: it could be a true finding arising from difficult to interpret
differences between exposure metrics, it could be the result of confounding by some unexpected
variable, or our results could be chance findings that resulted even after applying the FDR
adjustment. This is plausible due to the very large number of models run for each metric. If this
is the case, our results consist of chance findings, and the features identified as significant are not
actually a part of any causal pathway of interest to us, and instead, the null hypothesis that there
15

are no detectable changes in metabolomic profile would be accepted. If the null hypothesis is
correct, this could indicate that the exposure period utilized in this study was simply too short to
accurately measure changes in metabolic profiles, or it could indicate insufficient statistical
power to detect small changes in metabolomic profile. Further investigation is needed to
determine the cause of these inconsistencies.
5.2 Study Limitations:
While using saliva as a medium for identifying metabolic pathways is both inexpensive
and non-invasive, there are disadvantages associated with its use in this capacity. Saliva samples
were collected immediately prior to and following outdoor physical activity. Therefore, any
metabolic features that take more than a 2-hour window to become established in the body would
not have shown up in our analysis. Also, this method did not take into account any exposures to
air pollution or physical activity prior to the allotted sampling time period. Research has shown
that exposure to air pollutants in the previous 24-48 hours can impact health outcomes more
significantly than immediate acute exposures (Han & Naeher 2005). Additionally, saliva as a
medium does not include solely human metabolic processes but also contains byproducts from
bacterial metabolic processes (Ishikawa et al. 2016).
Additionally, our study methods involved measuring multiple factors simultaneously.
We attempted to control for this in our linear mixed regression models, but because some of the
factors are inherently correlated, we may not have separated them perfectly. Dose and physical
activity, for example, posed a significant challenge. These two factors are highly correlated with
each other (because dose is calculated using minute ventilation data), so disentangling the effects
caused by each is very important. We attempted to separate these confounding effects by
comparing regression models that controlled for activity with models that did not. For this
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portion of the analysis, we focused on BC and PNC because of their high biological relevance.
The significant metabolites found associated with dose while controlling for activity, dose while
not controlling for activity, and activity while not controlling for any pollutant metrics did not
overlap at all. When comparing models with dose as a predictor that did control for activity to
models that did not control for activity, we can suppress the biochemical effects of changes in
heart rate caused by activity. Although strongly influenced by physical activity, the cumulative
dose exposure metric is a function of several additional factors as well. For example, two persons
with similar activity levels could experience different inhaled doses if one person’s activity
occurred during time periods when pollutant concentration levels were low while the other
person’s occurred while concentrations were high. In addition, if the persons had different levels
of physical fitness with respect to aerobic activity, then the more fit person would experience a
smaller increase in ventilation rate for the same increase in the accelerometer-derived activity
parameter. Finally, FVC is an important predictor of dose and is also sensitive to height.
Therefore, a taller individual would have a higher inhaled dose than a shorter individual all else
being equal. Modeling dose poses a unique challenge because dose may be a function of body
and/or lung size in addition to high one-minute ambient concentration levels. We did not
separate these factors in our models, meaning that our dose measurements could change for
reasons related and unrelated to activity.
Due to the nature of the Mummichog analysis, small changes in an effect size could
potentially change the distribution of activated pathways. It is possible that this study does not
have enough statistical power to observe changes at the small levels of variation in pollution
metrics measured. Part of this problem occurs due to our study design in which participants’
exposures are measured over a course of hours rather than for days or weeks at a time.
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Although this study did not yield results that display a strong correlation between
pollution exposure and changes in metabolic profiles, especially across pollutant metrics, we
have reason to believe this area of study is promising in the early detection of disease. An
ongoing study in Atlanta using plasma metabolomics data to examine the effects of nearroadway air pollution exposure on metabolite production did find compelling results. The only
notable difference between the studies is that the exposure period utilized in their study is one
week rather than 2 hours. This suggests that acute pollution exposure may take more than 2
hours to have a measurable effect on the salivary metabolome. (Liang et al. n.d.)
It is critical to understand the challenges involved in interpreting untargeted, highresolution metabolomics data. We used an online metabolic database to identify statistically
significant metabolites in our study. Because the database of human metabolites is limited, many
significant results were left unknown after our final analysis.
5.3 Conclusions:
This study provided insight into the short-term effects of acute air pollution exposure on
metabolite production. We identified 48 metabolic pathways that showed significant correlation
with air pollution exposure. Current contributions to the field of untargeted, high-resolution
metabolomics data will allow future research to better explain the relationship between air
pollution exposure and metabolite production. Our research suggests that while high-resolution
metabolomics shows potential for reliably identifying biomarkers of pollutant-related stress,
there is still much room for further development in this field. As the number of identified
metabolites in online databases increases, programs such as Mummichog will develop the ability
to identify a growing number of metabolites and associated pathways.
Future challenges include standardizing data collection, analysis, and reporting methods.
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TABLES AND FIGURES
Table 1. Sample Characteristics
Characteristics
N (%)
Sex
Female
18 (31.58)
Male
39 (68.42)
Race
Black
11 (19.30)
White
41 (71.93)
Asian
5 (8.77)
*Age (yrs)
26.26 (7.94)
*Weight (kg)
70.83 (13.77)
*Height (cm)
172.45 (9.38)
2
*BMI (kg/m )
23.64 (3.35)
*Indicates values are Mean (SD)
Table 2. Mean Pollutant Metric Values
Pollutant Metric
Particulate Matter (PM2.5) (µg/m3)
Concentration
Exposure
Dose
Max
Particle Number Concentration (PNC) (particles/cm3)
Concentration
Exposure
Dose
Max
Black Carbon (BC) (µg/m3)
Concentration
Exposure
Dose
Max
Ozone (O3) (ppm)
Concentration
Exposure
Dose
Max
Activity
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Mean (SD)
13.23 (4.92)
1833.41 (649.97)
80.10 (40.01)
1.26 (0.51)
10.95 (3.35)
1644.69 (1051.28)
66.06 (32.30)
1.38 (0.55)
0.64 (0.17)
92.94 (30.23)
3.93 (1.58)
0.08 (0.05)
48.52 (12.53)
7414.25 (3813.63)
295.13 (112.85)
4.21 (1.07)
42.24 (12.77)

Table 3. Number of Significant Features per Pollutant Metric
Pollutant Metric
C18
HILIC
Total
Black Carbon (BC)
Concentration
61
79
140
Dose
41
48
89
Exposure
37
78
115
Max
48
39
87
Ozone (O3)
Concentration
39
53
92
Dose
45
47
92
Exposure
55
80
135
Max
32
65
97
Particulate Matter (PM2.5)
Concentration
41
58
99
Dose
28
63
91
Exposure
50
66
116
Max
29
60
89
Particle Number Concentration (PNC)
Concentration
52
66
118
Dose
70
89
159
Exposure
77
75
152
Max
73
99
172
Values represent the number of features that show significant associations with changes in each
pollutant metric after applying the FDR adjustment.
Table 4. Mummichog output:
a. HILIC Plasma Column
Overlap
Size

Pathway
Size

P-value
(Raw)

P-value1 Metric

Alanine and aspartate metabolism*

3

22

0.08029

0.00586

BC exp; O3 exp;
PNC conc, exp

Aminosugars metabolism
Androgen and estrogen biosynthesis and
metabolism

3

28

0.03517

0.00096

PNC conc

2

43

0.41914

0.03787

Arginine and proline metabolism*

3

38

0.18226

0.00319

Ascorbate (Vitamin C) and aldarate
metabolism

3

15

0.02524

0.00008

3

67

0.10978

0.00301

2

14

0.1234

0.00084

Pathway Name

Aspartate and asparagine metabolism
Beta-Alanine metabolism**

20

PNC dose
O3 exp; PNC dose,
exp, max
PNC max
O3 conc; PNC conc,
max; BC conc; PM
exp
O3 exp, max; PNC
exp, max; ACT

Biopterin metabolism

2

15

0.14613

0.01627

BC exp

Butanoate metabolism

2

22

0.11251

0.00473

PNC conc, exp; ACT

Carnitine shuttle

2

14

0.13733

0.01545

De novo fatty acid biosynthesis

2

19

0.20215

0.00189

Drug metabolism - other enzymes

2

17

0.08654

0.00125

PNC exp
PM max; PNC dose,
max; ACT
BC conc, exp; PM
dose; PNC exp, max

Fatty Acid Metabolism

2

16

0.15399

0.00118

PNC max

Galactose metabolism

2

38

0.35931

0.0291

PNC dose

Glutamate metabolism

2

12

0.03787

0.00177

Glutathione metabolism*

2

10

0.02669

0.00142

Glycerophospholipid metabolism*

2

42

0.30505

0.01998

Glycine, serine, alanine and threonine
metabolism

2

47

0.1991

0.0165

Glycolysis and gluconeogenesis**

3

39

0.19229

0.00345

Glycosphingolipid metabolism

2

25

0.09688

0.00603

O3 max

Hexose phosphorylation**

2

17

0.17882

0.02007

Histidine metabolism

4

21

0.00756

0.00035

Leukotriene metabolism*

3

44

0.16632

0.00455

Linoleate metabolism

3

19

0.04746

0.00012

Methionine and cysteine metabolism*

5

48

0.00724

0.00047

BC exp
O3 exp; PNC conc,
exp
PM max; PNC conc,
exp, max; BC dose
PNC conc, dose,
max
PNC conc, exp,
max; BC max, dose,
exp; O3 exp

Prostaglandin formation from arachidonate

3

57

0.46357

0.00624

Purine metabolism

5
48

0.06258

0.00367

PNC conc, exp
BC conc; PNC conc,
exp
O3 exp; PNC conc,
dose
BC conc, O3 conc,
PNC conc
O3 exp, PNC conc,
PM exp

PNC max, PM max
BC exp, dose; PM
conc; PNC conc,
dose
O3 exp; PNC conc,
exp
PNC conc, exp; O3
exp

Pyrimidine metabolism

3

41

0.21276

0.00404

Pyruvate metabolism

2

14

0.05052

0.00219

Saturated fatty acids beta-oxidation

2

9

0.05614

0.00031

PNC max, exp

Selenoamino acid metabolism

2

17

0.10183

0.00501

PM max, PNC exp

Squalene and cholesterol biosynthesis

2

25

0.18485

0.03975

BC conc, exp

TCA cycle

3

15

0.02753

0.00336

BC exp

21

Tyrosine metabolism*

3

85

0.3916

0.01797

Urea cycle/amino group metabolism*

3

47

0.124

0.00269

Vitamin B3 (nicotinate and nicotinamide)
metabolism

3

20

0.06349

0.00503

Vitamin B9 (folate) metabolism

3

13

0.02011

0.00305

Vitamin E metabolism*

2

23

0.08384

0.00511

O3 max

Xenobiotics metabolism*

2

54

0.32002

0.03786

O3 max

PNC conc
PNC conc, dose,
max; O3 conc,
dose; ACT
PNC conc, exp,
dose
PNC conc, exp; BC
exp

1

Mummichog-calculated p-value takes into consideration the number of metabolite overlaps on
given pathway.
*Pathways found in previous studies to be associated with air pollution exposure.
**Pathways found in previous studies to be associated with physical activity.
Values displayed are associated with most significant findings for each pathway.
b. C18 Plasma Column
Overlap
Size

Pathway
Size

P-value
(Raw)

P-value1 Metric

Alanine and aspartate metabolism

2

20

0.11455

0.01363

Androgen and estrogen biosynthesis and
metabolism

2

55

0.28777

0.00167

C21-steroid hormone biosynthesis and
metabolism

3

70

0.14908

0.00005

De novo fatty acid biosynthesis

2

16

0.03645

0.00001

Drug metabolism - cytochrome P450*

2

32

0.03351

0.00001

Galactose metabolism

2

36

0.12282

0.00914

Glycerophospholipid metabolism

2

39

0.19424

0.00006

Linoleate metabolism

2

19

0.05384

0.00556

BC conc

Lysine metabolism

2

22

0.22663

0.03218

PNC exp

N-Glycan biosynthesis

2

14

0.03047

0.00412

BC conc

Pentose and glucuronate
interconversions**

2

14

0.0283

0.00001

Porphyrin metabolism*

3

14

0.00681

0.00237

PNC dose

Purine metabolism

2

42

0.05525

0.00002

O3 dose

Pathway Name

22

PNC dose
PM conc; BC conc,
dose; PNC conc,
exp
PM conc; O3 exp,
dose; BC conc,
dose; PNC exp;
ACT
PM conc
O3 dose, PNC dose
BC dose
BC exp, PNC exp

PM conc

Pyrimidine metabolism

2

49

0.24386

0.00094

PM conc

Tryptophan metabolism

3

47

0.30195

0.02751

Tyrosine metabolism

2

83

0.08845

0.00506

PNC exp
BC max, PNC exp,
O3 exp

Urea cycle/amino group metabolism

3

40

0.22284

0.0158

Vitamin A (retinol) metabolism*

2

32

0.12497

0.00013

Xenobiotics metabolism

2

52

0.26579

0.00126

PNC exp
PM conc, dose;
PNC dose
PM conc

1

Mummichog-calculated p-value takes into consideration the number of metabolite overlaps on
given pathway.
*Pathways found in previous studies to be associated with air pollution exposure.
**Pathways found in previous studies to be associated with physical activity.
Values displayed are associated with most significant findings for each pathway.
Figure 1. Manhattan Plots for PNC max with FDR-corrected significance levels 0.05, 0.10, and
0.20 represented by the red, blue, and black lines, respectively
a.
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b.

Figure 1a. and 1b. represent the Manhattan plots for PNC max associations from the C18 and
HILIC datasets, respectively.
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Figure 2. Manhattan Plots for BC dose with FDR-corrected significance levels 0.05, 0.10, and
0.20 represented by the red, blue, and black lines, respectively
a.
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b.

Figure 2a. and 2b. represent the Manhattan plots for BC dose associations from the C18 and
HILIC datasets, respectively.
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